The condition: Macular edema occurs when the blood vessels leak plasma into the surrounding retina. Among people with type 2 diabetes, it can be found in 15% of those who use insulin and 4% of those who do not. Risk factors for macular edema and its symptoms are listed in Box 1. Cases of rosiglitazone-related macular edema were first described in September 2005. The manufacturer of the drug, Gl...

BACKGROUND/PURPOSE To report a case of congenital retinal macrovessel associated with cystoid macular edema and an ipsilateral intracranial venous malformation. METHODS Case report. RESULTS A 58-year-old woman with decreased vision was found to have a congenital retinal venous macrovessel associated with cystoid macular edema because of tributary venous occlusion. The patient underwent neur...

Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients. Laser photocoagulation, which is the standard treatment of macular edema, is associated with significant complications and an improvement in visual ac...

Macular edema is a common cause of visual loss in patients with retinal vein occlusions. Ozurdex(®), a dexamethasone intravitreal implant, has been shown in randomized controlled trials to reduce macular edema and improve visual acuity in patients with either branch retinal vein occlusions or central retinal vein occlusions. It was approved in the United States in 2009. Since then, new therapeu...

Purpose: We evaluated the macular, functional and structural features of patients with retinal vein occlusion macular edema. measured best-corrected visual acuity (BCVA), central foveal thickness, area avascular zone after intravitreal bevacizumab (IVB) treatment placement a dexamethasone implant (IVD).Methods: retrospectively reviewed 36 eyes edema who underwent IVB (20 eyes) IVD (16 eyes). Th...

The purpose of the study was to compare the effectiveness of intravitreal injection of tissue plasminogen activator and avastin with avastin on macular thickening and visual acuity in macular edema due to branch Retinal Vein Occlusion (BRVO) that had not received any treatment. In this double-blind randomized controlled trial, Fifty eyes of 50 patients with macular edema because of BRVO were ra...

BACKGROUND The purpose of this study was to investigate the effect of panretinal photocoagulation (PRP) on macular morphology and thickness in eyes with proliferative diabetic retinopathy (PDR) and without clinically significant macular edema. METHODS This was a prospective study of 76 eyes from 68 patients diagnosed to have PDR without clinically significant macular edema. Baseline and post ...

PURPOSE To evaluate the effects of vitrectomy and internal limiting membrane peeling for treatment of macular edema secondary to retinal vein occlusion (RVO). METHODS Nine cases of visual loss due to macular edema caused by central retinal vein occlusion or branch retinal vein occlusion underwent pars plana vitrectomy with removal of the preretinal hyaloid, peeling of the internal limiting me...

BACKGROUND The purpose of this retrospective chart review was to evaluate factors associated with improvement of visual acuity after a single sub-Tenon injection of triamcinolone acetonide in patients with diabetic macular edema. METHODS We reviewed the medical records for 63 consecutive eyes with diabetic macular edema treated by sub-Tenon injection of triamcinolone acetonide and assessed at...